Laser Therapy-Guidance for Early Laryngeal Carcinoma

Early laryngeal cancer: In stages 0, 1, and 2, the tumor is small. Cancer has not spread beyond the larynx. Laryngeal cancers that form on the vocal cords (glottis) often cause hoarseness or a change in the voice.

 Removing cancer through surgery is a common treatment for all stages of laryngeal cancer.

Laser therapy was pioneered in the early 1970s as an approach to treat laryngeal pathology with precision and minimal thermal damage to the vocal cords.

Over the last four decades, LLT has become an integral part of the treatment paradigm for patients with laryngeal cancer, especially with early-stage laryngeal tumors.

Undoubtedly, the quality of the laser devices used for treatment has been a determining factor that strongly impacted the recovery’s quality and duration.

The FDA Portable 980nm Surgery Laser System SIFLASER-1.2B for example has been recurrently used by a number of otolaryngologists viewing its high efficacy in treating such an issue.

This device’s blue laser light interacts better with the tissue components hemoglobin or melanin. At 980 nm, the machine performs better and gentler cutting, even at lower power.

As such, its Improved cutting performance makes it ideally suited to all surgical applications particularly removing laryngeal cancer.

What also makes the SIFLASER-1.2B highly recommended by otolaryngologists is that it displays an accurate alignment and exact sighting during the treatment. All thanks to its green aiming beam.

To further improve the treatment, the device is supported with a fiber guide laser. First, it is compatible with various endoscopic uses. Second, these special fibers are sterilizable which, in turn, prevents any possible cross-infection while guaranteeing a clean and bloodless operative area.

With a 980nm wavelength and 15W as maximum power, the device is thought to perfectly suit laryngeal cancer highly-sensitive surgeries.

That is highly attributed to the fact that The SIFLASER-1.2 B uses infrared wavelengths and ultra-blue light to ensure high-level performance. That actually reduces the thermal damage and its peculiar interaction with hemoglobin.

Due to all these features, the SIFLASER-1.2B guarantees increased cutting effectiveness, much higher than the one obtained with infrared lasers.

Additionally, the complete absence of water absorption helps drastically reduce the overheating of the surrounding tissues. This should further reinforce the laser treatment’s efficacy.

Lasers are a relatively recent addition to laryngeal surgery. Since their invention, laser use and applications have expanded rapidly. In this article, we discuss the benefits of laser therapy and precisely the efficacy of SIFLASER-1.2 B as a surgical laser device in healing such diseases

.
Reference: Guidance of laser therapy for early laryngeal carcinoma by mucosal wave changes,

Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFSOF is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each vein finder device.

The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional